Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 13 Sep 2024 | |
| Central Nervous System Diseases | Discovery | - | 13 Sep 2024 | |
| Eye Diseases | Discovery | - | 13 Sep 2024 | |
| Immune System Diseases | Discovery | - | 13 Sep 2024 | |
| Infectious Diseases | Discovery | - | 13 Sep 2024 | |
| Liver Diseases | Discovery | - | 13 Sep 2024 | |
| Metabolic Diseases | Discovery | - | 13 Sep 2024 | |
| Neoplasms | Discovery | - | 13 Sep 2024 | |
| Other Diseases | Discovery | - | 13 Sep 2024 | |
| Respiratory Diseases | Discovery | - | 13 Sep 2024 |





